Close Menu
Influential MagazineInfluential Magazine
  • Home
  • Latest News
  • Entrepreneurs
  • Business
  • Finance
  • Leadership
  • More
    • Web Stories
    • Editor’s Picks
    • Press Release

Subscribe to Updates

Get the latest business and finance news for entrepreneurs all around the world.

What's Hot
Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

May 27, 2025
Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

May 24, 2025
Are You Smarter Than a Billionaire?

Are You Smarter Than a Billionaire?

May 22, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
Influential MagazineInfluential Magazine
SUBSCRIBE
  • Home
  • Latest News
  • Entrepreneurs
  • Business
  • Finance
  • Leadership
  • More
    • Web Stories
    • Editor’s Picks
    • Press Release
Influential MagazineInfluential Magazine
Home » Trump Plan Would Tie Some Drug Prices to What Peer Nations Pay

Trump Plan Would Tie Some Drug Prices to What Peer Nations Pay

May 12, 20253 Mins Read Business
Trump Plan Would Tie Some Drug Prices to What Peer Nations Pay
Share
Facebook Twitter Reddit Telegram Pinterest Email

President Trump will sign an executive order on Monday aimed at lowering some drug prices in the United States by aligning them with what other wealthy countries pay, he said on Truth Social on Sunday evening.

The proposal he described, which alone cannot shift federal policy, is what he calls a “most favored nation” pricing model. Mr. Trump did not provide details about which type of insurance the plan would apply to or how many drugs it would target, but he indicated that the United States should pay the lowest price among its peer countries.

“Our Country will finally be treated fairly, and our citizens Healthcare Costs will be reduced by numbers never even thought of before,” he wrote in his social media post.

Any such plan will most likely be subject to challenges in court, and it is not clear whether it will pass legal muster, especially without action by Congress.

In his first term, Mr. Trump tried unsuccessfully to enact a version of this idea for Medicare, the health insurance program that covers 68 million Americans who are over 65 or have disabilities. That plan would have applied only to 50 drugs, administered at clinics and hospitals, that are paid for by Medicare. A federal court blocked it, ruling that the administration had skipped steps in the policymaking process.

The pharmaceutical industry bitterly opposes the idea, which would almost certainly cut into its profits, and has been lobbying against it as discussions of the policy have regained steam in Washington in recent weeks. Companies have warned that such a policy would lead them to spend less on research, depriving patients of new medicines.

“Government price setting in any form is bad for American patients,” Alex Schriver, an official at the drug industry’s main lobbying group, PhRMA, said in a statement. He added, “Policymakers should focus on fixing the flaws in the U.S. system, not importing failed policies from abroad.”

Mr. Trump’s embrace of the idea sets him apart from most Republicans, who have tended to be skeptical of government price setting. Democratic lawmakers have proposed versions of the idea.

Ameet Sarpatwari, an expert in pharmaceutical policy at Harvard Medical School, said that Mr. Trump was tapping into an idea that had “populist appeal.”

Mr. Trump has long complained that the United States pays much more than other wealthy countries do for the same drugs. And he is right. In the United States, prices for brand-name drugs are three times as high, on average, as those in peer nations.

That is in spite of the fact that much of the research that leads to new drugs takes place in American laboratories and hospitals.

Drugmakers generate a substantial majority of their worldwide profits from sales in the United States and typically design their business strategy around the U.S. market.

Pharmaceutical companies argue that the higher prices in the United States come with an added benefit: Industry-funded analyses have found that patients in the United States get medicines faster, and with fewer insurance restrictions, than those in other countries.

Donald J Drugs (Pharmaceuticals) Executive Orders and Memorandums Fees and Rates) Health Insurance and Managed Care Prices (Fares Trump United States Politics and Government
Share. Facebook Twitter Pinterest LinkedIn Telegram Reddit Email
Previous ArticleAsia Stocks Rise on Hope for Lower Tariffs After U.S.-China Talks
Next Article Can More Military Spending Revive an Economy? This British Town Hopes So.

Related Posts

Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

May 27, 2025
Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

May 24, 2025
Are You Smarter Than a Billionaire?

Are You Smarter Than a Billionaire?

May 22, 2025
Markets Head Lower in Wake of Concerns About U.S. Debt

Markets Head Lower in Wake of Concerns About U.S. Debt

May 19, 2025
Video: How Staffing Shortages Have Plagued Newark Airport

Video: How Staffing Shortages Have Plagued Newark Airport

May 17, 2025
Consumers Show Signs of Strain Amid Trump’s Tariff Rollout

Consumers Show Signs of Strain Amid Trump’s Tariff Rollout

May 15, 2025
Add A Comment

Leave A Reply Cancel Reply

Demo
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

By News RoomMay 27, 2025

new video loaded: Toy Company Still In Crisis Despite Reduced Tariffs on ChinatranscriptBacktranscriptToy Company Still…

Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

May 24, 2025
Are You Smarter Than a Billionaire?

Are You Smarter Than a Billionaire?

May 22, 2025
Wedding Belles Love Expands with Size-Inclusive, Same-Day Bridalwear Boutique

Wedding Belles Love Expands with Size-Inclusive, Same-Day Bridalwear Boutique

May 22, 2025

Subscribe to Updates

Get the latest business and finance news for entrepreneurs all around the world.

About Us
About Us

Influential Magazine is one of the top news portals about Business and Finance news for Entrepreneurs and leaders all around the world, follow us for more intersting articles and news.

Our Picks
Wedding Belles Love Expands with Size-Inclusive, Same-Day Bridalwear Boutique

Wedding Belles Love Expands with Size-Inclusive, Same-Day Bridalwear Boutique

May 22, 2025
Markets Head Lower in Wake of Concerns About U.S. Debt

Markets Head Lower in Wake of Concerns About U.S. Debt

May 19, 2025
Video: How Staffing Shortages Have Plagued Newark Airport

Video: How Staffing Shortages Have Plagued Newark Airport

May 17, 2025
Trending Now
Consumers Show Signs of Strain Amid Trump’s Tariff Rollout

Consumers Show Signs of Strain Amid Trump’s Tariff Rollout

May 15, 2025
Inside Elon Musk’s X Feed: Trumpism, Falsehoods and Lots of Love for Elon Musk

Inside Elon Musk’s X Feed: Trumpism, Falsehoods and Lots of Love for Elon Musk

May 15, 2025
World Economic Forum Investigating Allegations Against Founder Klaus Schwab

World Economic Forum Investigating Allegations Against Founder Klaus Schwab

May 15, 2025
Influential Magazine
Facebook X (Twitter) Instagram LinkedIn
  • Home
  • Privacy Policy
  • Contact
  • Terms & Conditions
© 2025 Influential Mag. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.